Annalisa Paviglianiti: Real-World Outcomes of Maribavir for CMV After Hematopoietic Cell Transplantation
Annalisa Paviglianiti, Hematologist at Hospital de la Santa Creu i Sant Pau, shared a post on LinkedIn about a recent article she and her colleges co-authored, published in The Lancet Infectious Diseases, adding:
“Excited to share that our article on maribavir is now published online!
This European cohort is the first to report such a large number of patients treated with MBV for CMV infection in the HCT setting.
Encouraging response rates, along with a favorable safety profile.
Promising outcomes, even beyond current EMA-approved indications.
Curious to hear how others are using MBV in practice?”
Title: Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study
Authors: Annalisa Paviglianiti, Per Ljungman, Rafael de la Camara, Gloria Tridello, Juana Schwartz, Nina Knelange, Arancha Bermudez Rodriguez, María Suárez-Lledó, Johan Maertens, Maria Stamouli, Francis Ayuk, Candela Ceballos, Maria Huguet, Felipe Peña Muñoz, Pablo Granados, Alienor Xhaard, Jurgen Kuball, Chiara Nozzoli, Jan Styczynski, Dina Averbuch, Francesca Kinsella, Alejandro Avendano, Hakan Ozodogu, Jose Rifon Roca, Nicole Morrow, Marta Stanzani, Marina Popova, Jerome Cornillon, Tsila Zuckerman, Massimo Martino, Johannes Clausen
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 22, 2026, 04:13Ilenia Calcaterra: Clinical Relevance of Persistent Pain in Emicizumab-Treated Haemophilia A
-
Apr 22, 2026, 03:56Annette Bowyer: Reflecting on Progress and Leadership in Laboratory Sciences
-
Apr 21, 2026, 21:07Tareq Abadl: Not Every Low Platelet Count Is True – Check the Smear First
-
Apr 21, 2026, 21:05Beverley Hunt: Honored to Receive the Lifetime Achievement Award at BSH 2026
-
Apr 21, 2026, 21:03Toong Youttananukorn: Proud to Support Data That Drives Action at WFH 2026
-
Apr 21, 2026, 20:48Ney Carter Borges: Endothelial Senescence as a Central Driver of Adipose Dysfunction in Heart Failure and Type 2 Diabetes
-
Apr 21, 2026, 20:29Can Stem Cell-Delivered Platelets Fight Drug-Resistant Bacteria?- RPTH Journal
-
Apr 21, 2026, 18:51WHO Expert Lorenzo Moja Discusses How Essential Medicines Policy Expands Access to Treatment – WFH
-
Apr 21, 2026, 18:35Ana Pedrero Gil: New ASH–ISTH 2026 Guidelines Focus on Preventing VTE in Children